| ARID1A | AT-rich interaction domain 1A |
| ATM | ATM serine/threonine kinase |
| ATR | ATR serine/threonine kinase |
| AUC | Area Under The Curve |
| BRAF | B-Raf proto-oncogene, serine/threonine kinase |
| BRCA1/2 | BRCA1/2 DNA repair associated |
| CA125 | cancer antigen 125 |
| CCNE1 | cyclin E1 |
| CD133 | prominin 1 |
| CD44 | CD44 molecule (Indian blood group) |
| CDK12 | cyclin-dependent kinase 12 |
| CDK14 | cyclin-dependent kinase 14 |
| ChIP-Seq | chromatin immunoprecipitation-sequencing |
| CNV | copy number variations |
| CpG | cytosine–guanine dinucleotides |
| CTCs | cancer tumour cells |
| ctDNA | circulating tumour cells |
| CTNNB1 | catenin beta 1 |
| DDR | DNA damage response |
| DNMT | DNA methyltransferase |
| DNMTi | DNA methyltransferase inhibitor |
| EMSY | EMSY transcriptional repressor, BRCA2 interacting |
| EMT | epithelial–mesenchymal transition |
| EOC | epithelial ovarian cancer |
| EpCAM | epithelial cell adhesion molecule |
| ERASMOS | Effects of Regional Analgesia on Serum miRNA after Oncology Surgery Study |
| ERBB2 | erb-b2 receptor tyrosine kinase 2 |
| FIGO | The International Federation of Gynecology and Obstetrics |
| FN1 | fibronectin 1 |
| FOXM1 | forkhead box M1 |
| gDNA | genomic DNA |
| GEO | Gene Expression Omnibus (database) |
| HDAC | histone deacetylase |
| HGP | The Human Genome Project |
| HG-SOC | high-grade serous ovarian cancer |
| HOXA10/11 | homeobox A10/A11 |
| HPLC | High-performance liquid chromatography |
| IL6/JAK/STAT3 | interleukin 6/Janus kinase/signal transducer and activator of transcription 3 |
| KLK6 | kallikrein-6 |
| KRAS | KRAS proto-oncogene, GTPase |
| LG-SOC | low-grade serous ovarian cancer |
| lncRNA | long non-coding RNA |
| M | metastatic region |
| MAPK/Erk | mitogen-activated protein kinases/extracellular signal-regulated kinase |
| MDR1 | multidrug resistance protein 1 |
| miRNA | microRNA |
| MLH1 | mutL homolog 1 |
| mRNA | messenger RNA |
| MS | Mass Spectrometry |
| ncRNA | non-coding RNA |
| NECC | New England Case Control study |
| NF1 | neurofibromin 1 |
| NFκB | Nuclear Factor Kappa B |
| NGS | Next Generation Sequencing |
| NMR | Nuclear magnetic resonance spectroscopy |
| NRAS | NRAS proto-oncogene, GTPase |
| OC | ovarian cancer |
| ORM1 | Orosomucoid 1 |
| P1/2 | primary tumour site |
| PI3K/AKT | phosphatidylinositol 3-kinase/protein kinase B |
| PI3K/RAS | phosphatidylinositol 3-kinase/RAS type GTPase family |
| PIK3CA | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha |
| PMP | pelvic mass protocol |
| PPP2R1A | protein phosphatase 2 scaffold subunit Alpha |
| PTEN | phosphatase and tensin homolog |
| RAD51B | RAD51 paralog B |
| RAD51C | RAD51 paralog C |
| RASSF1A | Ras association domain family 1 isoform A |
| RB1 | RB transcriptional corepressor 1 |
| RBPMS | RNA-binding protein, mRNA processing factor |
| scRNA-Seq | single-cell RNA sequencing |
| SERPINA1 | serpin family A member 1 |
| SNPs | single-nucleotide polymorphisms |
| SNV | single nucleotide variant |
| SWI/SNF | switch/sucrose non-fermentable chromatin remodelling complex |
| TCGA | The Cancer Genome Atlas |
| TP53 | tumour protein 53 |
| WNT | WNT signalling gene family |
| Wnt/β-Catenin | canonical Wnt pathway |